This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q59262254
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в січні 1986 wetenschappelijk artikel ശാസ്ത്രപ്രബന്ധം article publié dans la revue scientifique The Lancet scientific article published in The Lancet im Januar 1986 veröffentlichter wissenschaftlicher Artikel artículu científicu
p:P577
wds:Q59262254-40FF4252-1D2A-42C4-98B1-D9E03D07BFE8
wdt:P577
1986-01-01T00:00:00Z
p:P407
wds:Q59262254-875402C8-5AE4-4DD1-8224-26383B46C6C8
wdt:P407
wd:Q1860
p:P2860
wds:Q59262254-0A967C43-4054-4FC5-9284-DAADB35852DC wds:Q59262254-18076BDC-2CFE-4A1E-A9F0-CA1B0721A0E7 wds:Q59262254-1BBD542A-3BA7-4049-BE49-C881BC92D685 wds:Q59262254-3CA5BD4B-061A-43E8-902C-94CB07D7017F wds:Q59262254-C14CC66F-D860-4732-992F-DFD159E952AD wds:Q59262254-F9A8F2CD-59B2-4248-A86E-4266D0507594
wdt:P2860
wd:Q93638858 wd:Q71205838 wd:Q68810885 wd:Q71365459 wd:Q42461719 wd:Q71731323
p:P2093
wds:Q59262254-A41314B1-930F-40BA-8256-6C35BA3A524C wds:Q59262254-4EDF8A9A-89CF-4B31-BD01-74568921B8A8
wdt:P2093
N K Gibbs H Hönigsmann
rdfs:label
PUVA TREATMENT STRATEGIES AND CANCER RISK PUVA TREATMENT STRATEGIES AND CANCER RISK
skos:prefLabel
PUVA TREATMENT STRATEGIES AND CANCER RISK PUVA TREATMENT STRATEGIES AND CANCER RISK
schema:name
PUVA TREATMENT STRATEGIES AND CANCER RISK PUVA TREATMENT STRATEGIES AND CANCER RISK
p:P50
wds:Q59262254-B6D940E0-08A5-4F73-AD44-DD46CFF8EB7D
wdt:P50
wd:Q46963300
p:P1476
wds:Q59262254-3690A87C-39A6-462A-9DBF-C54792C8C080
wdt:P1476
PUVA treatment strategies and cancer risk
p:P304
wds:Q59262254-3A321778-62B3-415F-8835-FA4F5D415F45
wdt:P304
150-151
p:P31
wds:Q59262254-8665D79F-BA4F-40F5-BDDB-0E6D8F0E5333
wdt:P31
wd:Q13442814
p:P698
wds:Q59262254-98046525-5888-44A2-8229-2E31408B77C8
wdtn:P698
n11:2867364
wdt:P698
2867364
p:P1433
wds:Q59262254-29D9FBC9-364B-4377-9B5A-5C27EB6EB78A
wdt:P1433
wd:Q939416
p:P433
wds:Q59262254-CDDD66E9-0872-4795-B2DA-C260B908B3CE
p:P478
wds:Q59262254-5C38D5F3-A152-4A9A-B80F-80A1DE4333B0
wdt:P433
8473
wdt:P478
1
p:P356
wds:Q59262254-15EC68B6-D410-4F88-B3B3-E0C2735D1299
wdtn:P356
n8:S0140-6736(86)92283-X
wdt:P356
10.1016/S0140-6736(86)92283-X